NVUS - Novus Therapeutics misses by $0.09 March, 28 2019 08:06 AM Novus Therapeutics Inc. Novus Therapeutics (NASDAQ:NVUS): Q4 GAAP EPS of -$0.49 misses by $0.09.Cash and cash equivalents of $12.97MPress ReleaseMore news on: Novus Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,